20 May - 3 Jun 2021IPO
Odinwell AB has developed a technology based on fiber optics and fluorescent light for integration in plasters and wound treatment. The technology enables providers of medical solutions to change their current range of dressings with new ways of “seeing”.
By simply adding optical sensors to a dressing, a wide range of biomarkers indicating signs of infection, blood, fluids and pressure can be detected. The wound can be properly assessed in real time without the risk of disrupting the sensitive healing process by tearing off the bandage’s protective barrier. Associations with Odinwell technology have the potential to set a new global standard for wound care management. With more accurate and rapid dressing changes, results for patients, clinics and ours are rapidly improved. And by gaining new knowledge and insights into the healing process for a cover wound, a completely new range of products and solutions is possible.
The company is now conducting a rights issue prior to its listing on the Spotlight Stock Market.
The offer in summary
Record date: 18 May 2021
Subscription period: 20 May - 3 June 2021
Trading in subscription rights: No trading in subscription rights will take place.
Terms: Shareholders registered in the share register with Euroclear Sweden AB at the record date 18 May 2021 has pre- emptive right to subscribe for shares in the rights issue. One (1) share in the company entitles to one (1) subscription right. Seven (7) subscription rights entlitle to subscription of three (3) new shares in the Company.
Subscription price: 5.00 SEK per share
ISIN of the share: SE0015809967
Trading in BTA: The BTA will be traded from when the Company's shares and BTA are listed at Spotlight Stock Market.
First day of trading: 9 June 2021
Market: Spotlight Stock Market